Listed Products of GLP-1 Receptor Agonists (GLP-1RA) At present, 9 GLP-1 receptor agonist hypoglycemic drugs have been approved for marketing in the world, namely: exenatide, liraglutide, Exenatide extended-release (exenatide ER), albiglutide, dulaglutide , lixisenatide, benaglutide, semaglutide, polyethylene glycol loxenatide injection and oral semaglutide
A good GLP-1 program will come with nutritional counseling, or at least a reminder of the importance of a good diet in preventing nutrient deficiencies
The Conversation
Micah Eimer, a clinical assistant professor at Northwestern Medicine and senior author of the study, said the research was inspired by a pattern he noticed among patients taking GLP-1 medications
Subcutaneous or intramuscular: TB-500 is injected subcutaneously or intramuscularly depending on the indication